Shinpoong Pharmaceutical Co.,Ltd (KRX:019170)
8,440.00
-690.00 (-7.56%)
At close: Jun 8, 2026
KRX:019170 Revenue
Shinpoong Pharmaceutical Co.,Ltd had revenue of 54.53B KRW in the quarter ending March 31, 2026, a decrease of -1.59%. This brings the company's revenue in the last twelve months to 233.80B, up 5.08% year-over-year. In the year 2025, Shinpoong Pharmaceutical Co.,Ltd had annual revenue of 234.68B with 6.15% growth.
Revenue (ttm)
233.80B
Revenue Growth
+5.08%
P/S Ratio
2.02
Revenue / Employee
289.00M
Employees
809
Market Cap
473.05B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 234.68B | 13.59B | 6.15% |
| Dec 31, 2024 | 221.09B | 20.87B | 10.42% |
| Dec 31, 2023 | 200.23B | -9.06B | -4.33% |
| Dec 31, 2022 | 209.29B | 20.05B | 10.60% |
| Dec 31, 2021 | 189.24B | -8.51B | -4.31% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Daewoong | 2.08T |
| Dong-A Socio Holdings | 1.45T |
| Boryung | 1.03T |
| DongKook Pharmaceutical | 954.16B |
| Huons Global | 845.30B |
| Dong-A ST | 830.27B |
| JW Pharmaceutical | 789.95B |
| Huons | 616.80B |